Is Jubilant Pharmova Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Jubilant Pharmova Ltd (JUBLPHARMA.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Jubilant Pharmova Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Jubilant Pharmova Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Jubilant Pharmova Ltd?

Muslim investors may consider investing in Jubilant Pharmova Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Jubilant Pharmova Ltd classified as HALAL?

Musaffa determines the Shariah status of Jubilant Pharmova Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Jubilant Pharmova Ltd updated?

The Shariah compliance status of Jubilant Pharmova Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Jubilant Pharmova Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Jubilant Pharmova Ltd?

You can check the latest Shariah compliance status of Jubilant Pharmova Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

JUBLPHARMA.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 16, 2026

Report Source: 2026 3rd Quarter Report

Jubilant Pharmova Ltd. Stock Analysis JUBLPHARMA.NS

India Health Care Small Cap Report: Q3, 2026

Jubilant Pharmova Ltd. engages in the provision of basic organic chemicals. The Company’s segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Proprietary Novel Drugs, and Management Services. The Radiopharma segment comprises radiopharmaceuticals, including radio pharmacies. The Contract Development and Manufacturing Organisation-Sterile Injectables segment includes contract development and manufacturing organisation-sterile injectables products. The Generics segment includes solid dosage formulations. The Contract Research, Development and Manufacturing Organisation segment includes drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment includes patient-focused biopharmaceutical businesses working to address unmet medical needs in oncology and autoimmune diseases.

Key Statistics of Jubilant Pharmova Ltd (JUBLPHARMA.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹981.00₹1,014.70

Today's Open

₹1,004.95

Volume

54.24K

P/E Ratio (TTM)

19.06

52 Week Range

₹786.05₹1,248.00

Market Cap

148.20B

Avg. Volume

107.73K

Dividend Yield

0.50%

Financial Metrics & Statements of Jubilant Pharmova Ltd (JUBLPHARMA.NS)

FAQ's for Jubilant Pharmova Ltd (JUBLPHARMA.NS)

According to Musaffa’s Shariah screening methodology, Jubilant Pharmova Ltd (JUBLPHARMA.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.